DSM develop weight management ingredient

Branded as Fabuless by DSM, the new product helps control food intake without the sacrifice and discipline usually associated with dieting and weight control.

14/07/05 DSM Food Specialties and Lipid Technologies Provider AB (LTP) have signed an exclusive, worldwide sales and marketing agreement to promote a novel and unique weight management ingredient.

Branded as Fabuless by DSM, the new product helps control food intake without the sacrifice and discipline usually associated with dieting and weight control. Developed and marketed as Olibra by LTP, Fabuless triggers the natural appetite control mechanism and suppresses the hunger signals that would normally be sent hours after a meal. Consumers feel more satisfied than they would have been and consequently eat less.

According to DSM, extensive consumer research in the USA and Europe highlighted that a key issue in weight management was the difficulty and perceived sacrifice involved in consumers’ real efforts to control their food intake. The Fabuless brand was found to have strong appeal to a range of target groups and we are now focussing applications development activity to meet their defined needs, the company said. 

LTP develops, produces and commercialises lipid-based ingredients and formulations for functional food, skin care and drug delivery applications. Although LTP’s main focus is on the development of novel functional food ingredients and formulations, there has also been a development of products for use in dietary supplements.  LTP has in this area granted GNC in the USA exclusive rights to the use of Olibra in single dose containers.

www.dsm-foodspecialties.com